Sun Pharma - Sezaby To Strengthen U.S. Specialty Portfolio: Systematix

SPARC has received U.S. FDA approval for Sezaby (phenobarbital sodium) for the treatment of neonatal seizures.

Systematix Institutional Equities

21 Nov 2022, 09:32 AM IST

<div class="paragraphs"><p>Finished tablets cascade down the channels of a packaging machine at Sun Pharmaceutical Industries Ltd. (Source: Company website)</p></div>

Finished tablets cascade down the channels of a packaging machine at Sun Pharmaceutical Industries Ltd. (Source: Company website)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Sun Pharma - Sezaby To Strengthen U.S. Specialty Portfolio: Systematix

SPARC has received U.S. FDA approval for Sezaby (phenobarbital sodium) for the treatment of neonatal seizures.

Choose a plan